How can we widen the real of pre-competitive science? Dr. Johan Weigelt, Chief Scientist of the Structural Genomics Consortium at the Karolinska Institute, joined Pharma IQ to discuss the benefits for R&D restructuring, and how Public Private Partnerships (PPP) are enabling drug discovery.
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.
Reach PHARMAIQ professionals through cost-effective marketing opportunities to deliver your message, position yourself as a thought leader, and introduce new products, techniques and strategies to the market.
Already an IQPC Community Member? Sign in Here or Forgot Password
Sign up now and get FREE access to our extensive library of reports, infographics, whitepapers, webinars and online events from the world’s foremost thought leaders.